|
|
|
|
| Professor Anindita Roy wins mentorship award |
| |
|
Andi Roy, Professor of Paediatric Haematology in the Childhood Leukaemia Research Group, has been awarded the Sir Andrew McMichael Medal for excellent supervision and mentorship. The award is given annually to DPhil supervisors recognised as inspirational role models and guides, and who assist their trainees in achieving their potential.
|
|
|
|
Personal and Career Development Review
|
| |
|
|
|
|
|
| The Department of Paediatrics continues to focus internal efforts on increasing the uptake of PDRs (Personal Development Reviews) and CDRs (Career Development Reviews), and this year the two have been combined into one PCDR (Personal Career Development Review).
The conversation is designed to help staff identify career goals and training objectives, agreeing a schedule and process with their line manager for the coming year, and establishing specific goals and a timeline for completion. All staff are strongly encouraged to undertake their PCDR in September and October and the HR Team will be touring all research groups to showcase why the review is important and how to conduct it. The team will also give some advice and guidance on using Simitive (the program used to record PCDRs).
Below are links to some useful resources:
|
|
|
|
Notices
Centre for Creative Brain Committee
|
| |
|
Students, researchers and staff are invited to join the Centre for Creative Brain Committee, to organise innovative neuroscience events and collaborate with leading experts. The committee is looking for scientists and academics from other disciplines to tackle the great questions pertaining to neuroscience and beyond.
Roles needed:
- Tech Operations Specialist (ideal for CompSci/Eng UG/PG!)
- Creative Arts Advisors (ideal for humanities UG/PG!)
- Media Coordinator
- Visual Communications Lead
- Finance Manager
- St Edmund's Hall Liaison Officer
- Speaker Engagement Specialists
|
|
|
|
| |
| |
|
| Hidden Research Excellence Framework (REF) competition
|
| |
|
The Hidden REF was launched to raise awareness of the research outputs and roles that are vital to research but overlooked by traditional research evaluation and are currently accepting nominations. Please consider taking part in the competition if you work in research and want to raise awareness of your own work or the work of others.
The deadline for nominations is Friday 13 September. There are two categories for nomination:
- Nominate a great colleague - people whose work has been instrumental in the conduct of your research.
- Nominate your work - any work that contributes towards research success, but which is not best represented by traditional research outputs.
|
|
|
|
| |
| |
|
| Trusted Research/ Research Assurance Informational Surgery
|
| |
|
The UK Government and research funders are currently using a range of measures to address risk in international research collaborations. To help departments navigate the changing landscape of Trusted Research, Research Services regularly hosts a series of Trusted Research & Assurance Surgeries. These surgeries are open to researchers, departmental support staff, divisional representatives and RS colleagues to discuss all aspects of Trusted Research and Assurance including, export control, NSI and due diligence on international collaborations.
The next surgery will take place on Wednesday, 25 September between 10am and 3pm in the Rivendell Meeting Room, 5 Worcester Street.
The deadline for timeslot bookings is Monday 23rd September. Please email via the link below to book. To enable a better-quality information session, upon booking, we ask you to clarify your particular area of interest:
- Export Control as it relates to your department
- Due Diligence for third parties
- Managing risk
- Information on National Security Investment Act and other legislation involving international collaborative research
- Questions regarding a specific case
|
|
|
|
| |
| |
|
Panacea Stars Develop Autumn/Winter 24/25 applications open
|
| |
|
Since its inception in Oxford in 2015, Panacea has been pivotal in the formation of over 400 companies, propelling its top 60 to a combined valuation of approximately £1.5bn. It is committed to advancing health-related innovations, from early-stage ideas to ready-for-market products. Its equity-free programs offer significant benefits: up to £100k in prizes, complimentary lab space, and wide-ranging support in scientific, clinical, financial, and legal aspects. The standout companies gain priority access to pre-seed and seed investments through Panacea Ventures.
Panacea is inviting the next wave of innovators to its equity-free Develop Programme Autumn/Winter 2024/25 cohort. The deadline for applications is 21 October 2024 at 11:59 pm GMT.
Apply now at Panacea Stars Develop Application. |
|
|
|
| |
| |
|
Business and Operations Manager Network (BOM) Meeting
|
| |
|
| The Business and Operations Manager Network (BOM) will be hosting its first thematic meeting to discuss the challenges related to space management within the University. The meeting will be held on Monday 21st October at 11.30am in the Botnar Institute. Anyone interested in joining this meeting and/or the network, is asked to email Iris Hofmann or Matthew Brack. |
|
|
|
| |
| |
|
|
|
Alarming headlines about IT security are never far away, but we can all take steps to protect ourselves and the University. The Information Security and Information Compliance teams released a new Information Security and Data Protection Staff training earlier in the summer, updated to reflect the ever evolving threats in the cyber environment.
|
|
|
|
| |
| |
|
|
|
|
| Industry Insights Seminar |
| |
|
5 September 2024 | Online Only | 12pm
Title: Prevention is better than cure – realising a sustainable new paradigm to predict and pre-empt obesity and its consequences
Speaker: Professor Nadeem Sarwar (Corporate Vice President, Co-Founder and Head, Transformational Prevention Unit)
Company: Novo Nordisk |
|
|
|
|
| |
| |
|
|
|
|
| Epigenetics: the apex of innate immune memory |
| |
|
| 6 September 2024 | IDRM seminar rooms | 3pm
Professor Musa M. Mhlanga is the chair of Cell Biology at the Radboud Institute for Molecular Life Sciences. He also heads the Laboratory for Epigenomics & Single Cell Biophysics. Musa did his undergraduate degree in France & the US and obtained his PhD in New York at NYU School of Medicine and The Rockefeller University. There, he worked on the development of molecular beacons for in vitro diagnostics and for the imaging of RNA in living cells with Fred R. Kramer & Sanjay Tyagi. Next, he did a Post Doctoral fellowship at the Institut Pasteur in Paris as a US National Science Foundation fellow. He worked on gene expression and nuclear organisation with a focus on imaging of RNA and transcription. His laboratory works on the epigenome with an emphasis on the role of noncoding RNA in genomic architecture and gene regulation, using the immune system as a model. This includes fundamental mechanisms of gene regulation and extends to large scale clinical studies. His lab also works on single cell epigenomics and spatial transcriptomics, using multiple omics and microscopy approaches in translational models.
|
|
|
|
|
| |
| |
|
|
|
|
| New Therapeutic Approaches in Translational Mental Health |
| |
|
16 September 2024 | Maths Institute | All day
This in-person conference is hosted by the Oxford Health BRC and sponsored by the UK Mental Health Mission. The event aims to bring together industry, academic & clinical researchers, the regulator and government research funding organisations to discuss the current challenges facing therapeutic development. The overall objective is to forge collaborations that can increase capacity and capability through partnerships to deliver paradigm changes in translational mental health research. The event includes keynotes, lightning talks, roundtable discussion and industry led workshop sessions by Angelini Pharma, Big Health, Boehringer Ingelheim, Karuna Therapeutics and Reckitt Benckiser. |
|
|
|
|
| |
| |
|
|
|
|
|
|
24 to 26 September 2024 | In person | Trinity College Oxford
The Oxford-Harrington Rare Disease Centre (OHC) Symposium is the UK’s leading academic-industry rare disease conference, bringing together in-person delegates from both areas as well as key stakeholders in rare disease therapeutics development. Over three days, from 24-26 September 2024, presentations and panel discussions will be delivered by international leaders in the field.
The Symposium’s theme, Therapeutics Development for Rare Diseases, will explore how pioneering research, innovative treatment approaches, and collaborative efforts across biotech, pharma, academic institutions, funders, patient organisations, and regulators can enhance and accelerate the delivery of effective therapies for rare diseases. Limited spaces are available.
View the full programme. |
|
|
|
|
| |
| |
|
|
|
|
| Why are so many of us burnt out, and what we can do about it? |
| |
|
26 September 2024 | Online only | Seminar 11-12; Workshop 13.30 to 15.00
Why do ever more of us find it so hard to find a good balance between life and work? The dramatic rise of work-related suffering is clearly not the problem of just a handful of people who are bad at time management.
This seminar will explore some of the deeper cultural reasons for why we are all so burnt out and offer some practical, actionable advice on what we can do about our exhaustion and how we can re-learn how to thrive.
Sign up for the Seminar here: https://forms.office.com/e/0cyFgdacJp
The workshop is now full but please email iris.hofmann@idrm.ox.ac.uk if you would like to join the waiting list. |
|
|
|
|
| |
| |
|
|
|
|
| Reflecting on who we are in the research environment |
| |
|
| 16 October 2024 | Hybrid | Seminar 11-12pm; Workshop 13.30 to 15.00
Inclusion, Intersectionality and Impact Specialist Dr Arun Verma, will be sharing his story and experiences as a queer person of colour, who has moved between and beyond categories and characteristics. He will be hosting both a seminar and a workshop at the IDRM on 16 October.
The Seminar will:
- Build confidence with what intersectionality is and how it applies to your everyday work
- Understand how equality issues are interconnected
- Develop small acts of kindness that can transform daily interactions
The workshop will explore intersectionality in more depth and focus on the following:
- Reflecting on where intersectionality comes from and why it matters
- Space to explore your own characteristics and stories
- Co-creating the big picture of an optimal research culture
We have 15 spaces available and registration is open now. There will also be a networking lunch in the IDRM Cafe after the seminar to which all are invited. Please reserve your place at lunch here. |
|
|
|
|
| |
| |
|
Can you help these trials?
|
| |
|
|
|
|
|
| Oxford Vaccine Group would like to invite you to take part in a study investigating how two common respiratory germs alter the environment in your nose and impact human health. The knowledge gathered in this project could be used to help develop new interventions such as anti-virus agents and drugs targeting the host body response. If you are 18 to 55 years old, you may be eligible to take part. We will provide reimbursement for your time, inconvenience and travel. The study duration is approximately 10 weeks. If you would like to find out more, please read the Participant Information Sheet. If you are interested in joining the study, please visit the Pre-screening Questionnaire via the link below. |
|
|
|
|
|
|
|
| We need volunteers for a new vaccine against Marburg virus |
| |
|
| If you are aged 18 to 55 years old and in good health, then you may be eligible to take part in a study investigating a new vaccine against Marburg virus. All participants will be reimbursed up to £1290 for their time, inconvenience, and travel. For further information please click on the link below. Here is a link to pre-screening questionnaire: Pre-screening Questionnaire or contact Oxford Vaccine Group with any questions: Email: info@ovg.ox.ac.uk Tel: 01865611400. |
|
|
|
|
|
|
|
|
|
| Oxford Vaccine Group would like to invite you to take part in a study in a challenge study to find a vaccine against malaria. The total study participation time is 18 months. If you would like any further information regarding the study please contact info@ovg.ox.ac.uk, or call 01865 611400 |
|
|
|
|
|
|
|
|
|
| Oxford Vaccine Group is looking for volunteers to help us understand how our immune systems respond to repeated infection with malaria. By taking part in this challenge study, you could help the research aimed at preventing hundreds of thousands of child deaths. If you are aged 18 to 45 years old, in good health and live in the Thames Valley, then you may be eligible to take part in the BIO-004 study. All participants will be reimbursed for their time, inconvenience and travel up to £9,100. |
|
|
|
|
|
